cisapride has been researched along with Belching in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of cisapride therapy in relieving symptoms of functional dyspepsia." | 9.08 | Efficacy of cisapride therapy in functional dyspepsia. ( Cowan, H; Eckstein, RP; Höschl, R; Kellow, JE; Lam, SK; Lunzer, MR; Riley, JW; Shuter, B, 1995) |
| "Cisapride and ranitidine improved the symptoms of diffuse epigastric pain, postprandial epigastric fullness, epigastric distension, belching, heartburn, regurgitation, and nausea when compared with baseline." | 9.08 | Cisapride compared with ranitidine in the treatment of functional dyspepsia. ( Carvalhinhos, A; Fidalgo, P; Freire, A; Matos, L, 1995) |
| "We evaluated the efficacy and safety of a twice-daily dosage regimen of cisapride 20 mg in relieving the symptoms of mild-moderate gastroesophageal reflux disease (GERD) in patients with moderate intensity heartburn and no history of erosive esophagitis." | 9.08 | Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. ( Castell, DO; Clyde, C; Hasner, D; Lambert, R; Patterson, D; Sigmund, C; Zeldis, JB, 1998) |
| "To assess the efficacy of cisapride therapy in relieving symptoms of functional dyspepsia." | 5.08 | Efficacy of cisapride therapy in functional dyspepsia. ( Cowan, H; Eckstein, RP; Höschl, R; Kellow, JE; Lam, SK; Lunzer, MR; Riley, JW; Shuter, B, 1995) |
| "Cisapride and ranitidine improved the symptoms of diffuse epigastric pain, postprandial epigastric fullness, epigastric distension, belching, heartburn, regurgitation, and nausea when compared with baseline." | 5.08 | Cisapride compared with ranitidine in the treatment of functional dyspepsia. ( Carvalhinhos, A; Fidalgo, P; Freire, A; Matos, L, 1995) |
| "We evaluated the efficacy and safety of a twice-daily dosage regimen of cisapride 20 mg in relieving the symptoms of mild-moderate gastroesophageal reflux disease (GERD) in patients with moderate intensity heartburn and no history of erosive esophagitis." | 5.08 | Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. ( Castell, DO; Clyde, C; Hasner, D; Lambert, R; Patterson, D; Sigmund, C; Zeldis, JB, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kellow, JE | 1 |
| Cowan, H | 1 |
| Shuter, B | 1 |
| Riley, JW | 1 |
| Lunzer, MR | 1 |
| Eckstein, RP | 1 |
| Höschl, R | 1 |
| Lam, SK | 1 |
| Carvalhinhos, A | 1 |
| Fidalgo, P | 1 |
| Freire, A | 1 |
| Matos, L | 1 |
| Castell, DO | 1 |
| Sigmund, C | 1 |
| Patterson, D | 1 |
| Lambert, R | 1 |
| Hasner, D | 1 |
| Clyde, C | 1 |
| Zeldis, JB | 1 |
3 trials available for cisapride and Belching
| Article | Year |
|---|---|
Efficacy of cisapride therapy in functional dyspepsia.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Dyspepsia; Eructation; Female; Gastric Emp | 1995 |
Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Topics: Adult; Antacids; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Dyspepsia; Eructation; Female; F | 1995 |
Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
Topics: Adolescent; Adult; Aged; Antacids; Cisapride; Eructation; Female; Gastroesophageal Reflux; Gastroint | 1998 |